Cellevate AB

Cellevate AB is an innovative biotech company with the slogan "Innovative biotech company developing next generation of cell culture systems designed to revolutionize biomanufacturing." Founded in 2014 and headquartered in Sweden, the company develops and markets products based on a proprietary nanofiber-based platform - the Cellevat3d™ - with the potential to revolutionize upstream bioprocessing from R&D to commercial manufacturing. Their latest product line in development – Cellevat3d™ carriers – with a commercial launch planned for 2024, provides extracellular-like environments with exceptional surface areas for adherent cell cultures, showing tremendous potential to increase yields, minimize risk, and reduce costs in development and manufacturing. The company offers a range of products based on their versatile and easily functionalized platform for several applications, including next-generation cell- and gene therapies. Their recent milestone includes securing a kr39.00M Seed Round investment on 10 October 2023 from investors such as Industrifonden, The European Innovation Council, and Onsight Ventures. For more information, please visit www.cellevate.com.